Oct 10, 2011
from 11:45 AM to 01:00 PM
|Where||Joseph S. Pagano Conference Room, LCCC|
|Contact Name||Lori Smith|
|Add event to calendar||
Myriad RBM invites you to a scientific seminar organized by Troy Tremaine, Director of Business Development for Myriad RBM
The "Myriad RBM Approach" to biomarker discovery and validation has proven itself to be one of the most successful commercially available methodologies. With over 3,000 studies concluded to date and dozens more being performed each month, our Multi-Analyte Profiles (MAPs) have become a valuable technology for academic, translational, and clinical biomarker research in many different therapeutic areas such as oncology, toxicology and neurobiology. This presentation will introduce you to the “Myriad RBM Approach” for biomarker discovery and detail several successful examples of how this approach has been applied in both academic and industry settings.